NFKB1 and amyotrophic lateral sclerosis: Seminal research by Swarup et al. [11] first implicated the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway as a crucial factor in the pathogenesis of ALS, directly linking it to TDP-43 pathology.